PATENT CLAIM ANALYSIS

Application Number: 15511428
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-05
Patent Classification: ["424", "449000"]

Abstract:
Disclosed herein are compositions that are useful in effecting the transdermal delivery of active agents such as opipramol. More particularly, the disclosed transdermal compositions include an active agent; one or more plasticizers; one or more penetration enhancers; a pressure-sensitive adhesive; and may include one or more hydrophilic polymers.

Claim (Index 53):
A method of treating a patient having a disorder selected from the group consisting of central nervous system (CNS) disorders, peripheral nervous system disorders, factitious disorders, somatoform disorders, inflammatory disorders, and pain-related disorders, said method comprising the steps of:\n a. providing a transdermal delivery device according to  claim 45 ; and b. placing an adhesive layer of the device against the skin of the patient, thereby providing an amount of opipramol effective to treat the disorder.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 88.0
- Lexical Diversity: 1.41026
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13885512', '14539824', '15027905', '13501500', '14550514']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7333403805507014
- 35 USC 102 Novelty (BERT): 0.525240031718611
- Combined Prediction Score: 0.7125303456674924
- Mean Citation Score: 249.108906
- Max Citation Score: 313.2574
- Similarity Product: 204.9992993846178

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test